Summary
Machine-generated summaryNHS Blood and Transplant (NHSBT) in the United Kingdom has published a preliminary market engagement notice for cryopreservation-grade dimethyl sulfoxide (DMSO) used to preserve stem cell and immunotherapy products. The expected requirement covers sterile, pyrogen-free DMSO with a minimum purity of 99.9%, supplied in vials, bottles, bags and/or syringes for NHSBT Cellular and Molecular Therapies laboratories. NHSBT is seeking information on products, supply chain capability, packaging, quality standards, innovation, sustainability and market capacity ahead of a potential future procurement exercise. This is not a call for tenders, no estimated value is stated, and no bid deadline applies.
Description
Official source
Source: Find a Tender Service (UK Cabinet Office / Crown Commercial Service)
Always verify details on the official notice.
Last verified against Find a Tender Service (UK Cabinet Office / Crown Commercial Service) 1 month ago
More from this buyer
Full buyer profile4 open tenders right now
- Occupational Driver Training 7 days left
- Technical Implementation Partner & Business Change Partner (DASP) 14 days left
- Supply and Support of High Through Put DNA Extraction Systems (long term) 21 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| QIAGEN LTD | 1 | €1.5M | Jul 2026 |
| Miltenyi Biotec | 1 | €563,005 | Jul 2026 |
| Alpha Laboratories Limited | 1 | €122,714 | Aug 2026 |
Based on 3 awards with a linked company profile over the last 5 years.
Similar tenders
6
days left
€2,711,686
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,804,288
- Buyer track record on Aperlena
- 43 notices tracked · 31 awarded
- €20,179,103 in awarded contracts
Never miss a tender like this
120 new notices in Medical equipment & pharmaceuticals in United Kingdom in the last 7 days. Get an email when new ones appear. Free.
Set up my alert